A Double Blind, Randomised, Placebo Controlled, Feasibility Phase III Clinical Trial of Peri-operative Immune-enhancing Feed in Patients Undergoing Surgery for Advanced Head and Neck Cancer
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Systemic infection
Lower respiratory tract; Gastro-intestinal tract; Urinary tract; Haematological.
30 days post surgery
No
Terence M Jones, MD
Principal Investigator
University of Liverpool
United Kingdom: National Health Service
EC.73.03
NCT01314755
November 2003
July 2008
Name | Location |
---|